Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads

Circulation

Volumn 98, Issue 15, 1998, Pages 1517-1524

  Epstein, Andrew E ^a   Kay, G Neal ^a   Plumb, Vance J ^a   Dailey, Sharon M ^a   Anderson, Peter G ^b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Arrhythmia; Death, sudden; Defibrillation; Fibrillation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MALE; PATHOLOGY; PRIORITY JOURNAL;

EID: 0032514609     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.15.1517     Document Type: Article

References (43)

1. Schuder JC, Stoeckle H, Gold JH, West JA, Holland JA. Ventricular defibrillation in the dog using implanted and partially implanted electrode systems. Am J Cardiol. 1994;33:243-247.
2. Van Vleet JF, Tacker WA. Cechner PE, Bright RM, Greene JA, Raffee MR, Geddes LA, Ferrans VJ. Effect of shock strength on survival and acute cardiac damage induced by open-thorax defibrillation of dogs. Am J Vet Med. 1978;39:981-987.
3. Doherty PW, McLaughlin PR, Billingham M, Kernoff R, Goris ML, Harrison DC. Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol. 1979;23:225-232.
4. Koning G, Veefkind AH, Schneider H. Cardiac damage caused by direct application of defibrillator shocks to isolated Langendorff-perfused rabbit heart. Am Heart J. 1980;100:473-482.
5. Fain ES, Billingham M, Winkle RA. Internal cardiac defibrillation: histopathology and temporal stability of defibrillation energy requirements. J Am Coll Cordiol. 1987;9:631-638.
6. Harman D, Matthews R, Gilli N, McCulloch R. Differences in the pathological changes in dogs' hearts after defibrillation with extrapericardial paddles and implanted defibrillator electrodes. PACE Pacing Clin Electrophysiol. 1991;14:358-361.
7. Singer I, Hutchins GM, Mirowski M, Mower MM, Veltri EP, Guarnieri T, Griffith LSC, Watkins L, Juanteguy J, Fisher S, Reid PR, Weisfeldt ML. Pathologic findings related to the lead system and repeated defibrillations in patients with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 1987;10:382-388.
8. Avital B, Port S, Gal R, McKinnie J, Tchou P, Jazayeri M, Troup P, Akhtar M. Automatic implantable cardioverter/defibrillator discharges and acute myocardial injury. Circulation. 1990;81:1482-1487.
9. Van Vleet JF, Schollmeyer MP, Engle WR, Tacker WA, Bourland JD. Cardiovascular alterations induced by chronic transvenous implantation of an automatic defibrillator electrode in dogs. J Electrocardiol. 1981; 14:67-72.
10. Van Vleet JF, Ferrans VJ, Barker MA, Tacker W, Bourland JD, Schollmeyer MP. Ultrastructural alteration in the fibrous sheath, endocardium, and myocardium of dogs shocked with chronically implanted automatic defibrillator leads. Am J Vet Res. 1982;43:909-915.
11. Barker-Voelz MA, Van Vleet JF, Tacker WA, Bourland JD, Geddes LA, Schollmeyer MP. Alterations induced by a single defibrillating shock applied through a chronically implanted catheter electrode. J Electrocardiol. 1983;16:167-179.
12. Van Vleet JF, Tacker WA, Bourland JD, Kallok MJ, Schollmeyer MP. Cardiac damage in dogs with chronically implanted automatic defibrillator electrode catheters and given four episodes of multiple shocks. Am Heart J. 1983;106:300-307.
13. Oyama K, Lee R, Ott GY, Haupt DW, Reynolds B, Halperin BD. Cardiac histopathology associated with nonthoracotomy lead systems. Circulation. 1994;90(suppl I):I-122. Abstract.
14. Schirmer U, Hemmer W, Lindner KH, Anhäupl T, Wieser T. Ultrastructural alterations in the right and left ventricular myocardium following multiple low energy endocardial countershocks in anesthetized dogs. Pacing Clin Electrophysiol. 1997;20:79-87.
15. Epstein AE, Anderson PG, Kay GN, Dailey SM, Plumb VJ, Shepard RB. Gross and microscopic changes associated with a nonthoracotomy implantable cardioverter-defibrillator. PACE Pacing Clin Electrophysiol. 1992;15:382-386.
16. Perkins DG, Klein GJ, Silver MD, Yee R, Jones DL. Cardioversion and defibrillation using a catheter electrode: myocardial damage assessed at autopsy. PACE Pacing Clin Electrophysiol. 1987;10:800-804.
17. Jones GK, Swerdlow C, Reichenbach DD, Lones M, Poole JE, Dolack GL, Kudenchuk PJ, Bardy GH. Anatomical findings in patients having had a chronically in-dwelling coronary sinus defibrillation lead. Pacing Clin Electrophysiol. 1995;18:2062-2067.
18. Stokes K, Borazin G. The electrode-biointerface. In: Barold SS, ed. Modern Cardiac Pacing. Mount Kisco, NY: Futura Publishing Co; 1985: 33-77.
19. Stokes K, Anderson J, Low threshold leads: the effect of steroid elution. In: Antonioli GE, Aubert AE, Ector H, eds. Pacemaker Leads 1991. Amsterdam, Netherlands: Elsevier Science Publishers BV; 1991: 537-542.
20. Mond HG, Stokes KB. The electrode tissue interface: the revolutionary role of steroid elution. PACE Pacing Clin Electrophvsiol. 1992;15: 95-107.
21. Anderson JM. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol. 1993;2:33S-41S.
22. Epstein AE, Plumb VJ, Kirk KA, Kay GN. Pacing threshold increase in nonthoracotomy implantable defibrillator leads: implications for battery longevity and margin of safety. J Interventional Cardiac Electrophysiol. 1997;1:131-134.
23. Venditti FJ, Martin DT, Vassolas G, Bowen S. Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator. Circulation. 1994;89:216-223.
24. Schwartzman D, Callans DJ, Gottlieb CD, Heo J, Marchlinski FE. Early postoperative rise in defibrillation threshold in patients with nonthoracotomy defibrillation lead systems: attenuation with biphasic shock waveforms. J Cardiovasc Electrophysiol. 1996;7:483-493.
25. Daoud EG, Man KC, Morady R, Strickberger SA. Rise in chronic defibrillation energy requirements necessitating implantable defibrillator lead system revision. Pacing Clin Electrophysiol. 1997;20:714-719.
26. Schwartzman D, Hull ML, Callans DJ, Gottlieb CD, Marchlinski FE. Serial defibrillation lead impedance in patients with nonthoracotomy lead systems. J Cardiovasc Electrophysiol. 1996;7:697-703.
27. Jung W, Manz M, Moosdorf R, Lüderitz B. Failure of an implantable cardioverter-defibrillator to redetect ventricular fibrillation in patients with a nonthoracotomy lead system. Circulation. 1992;86:1217-1222.
28. Brady PA, Friedman PA, Stanton MS. Effect of failed defibrillation shocks on electrogram amplitude in a nonintegrated transvenous defibrillation lead system. Am J Cardiol. 1995;76:580-584.
29. Callans DJ, Swarna US, Schwartzman D, Gottlieb CD, Marchlinski FE. Postshock sensing performance in transvenous defibrillation lead systems: analysis of detection and redetection of ventricular fibrillation. J Cardiovasc Electrophysiol. 1995;6:604-612.
30. Dahl CF, Ewy GA, Warner ED, Thomas ED. Myocardial necrosis from direct current countershock: effect of paddle electrode size and time interval between discharges. Circulation. 1974;50:956-961.
31. Babbs CF, Tacker WA, Van Vleet JF, Bourland JD, Geddes LA. Therapeutic indices for transchest defibrillator shocks: effective, damaging, and lethal electrical doses. Am Heart J. 1980;99:734-738.
32. Van Vleet JF, Tacker WA, Geddes LA, Ferrans VJ. Sequential cardiac morphologic alterations induced in dogs by single transthoracic damped sinusoidal waveform defibrillator shocks. Am J Vet Res. 1978;39: 271-278.
33. McDonald KM, Francis GS, Carlyle PF, Hauer K, Matthews J, Hunter DW, Cohn JN. Hemodynamic, left ventricular structural and hormonal changes after discrete myocardial damage in the dog. J Am Coll Cardiol. 1992;19:460-467.
34. Geddes LA, Ragheb AO, Janas W. A selective, non-ischemic, non-pharmacological left ventricular failure animal model. PACE Pacing Clin Electrophysiol. 1994;17:312-320.
35. Roberts WC, Ferrans VJ, Buja LM. Pathologic aspects of the idiopathic cardiomyopathies. Adv Cardiol. 1974;13:349-367.
36. Unverferth DV, Baker PB, Swift SE, Chaffee R, Fetters JK, Uretsky BF, Thompson ME, Leier CV. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol. 1986;57:816-820.
37. Hii JTY, Gillis AM, Wyse DG, Sheldon RS, Duff HJ, Mitchell LB. Risks of developing supraventricular and ventricular tachyarrhythmias after implantation of a cardioverter-defibrillator, and timing the activation of arrhythmia termination therapies. Am J Cardiol. 1993;71:565-568.
38. Estes NAM, Haugh CJ, Wang PJ, Manolis AS. Antitachycardia pacing and low-energy cardioversion for ventricular tachycardia termination: a clinical perspective. Am Heart J. 1994;127:1038-1046.
39. Pinski SL, Fahy GJ. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation. 1995;92:1651-1664.
40. Fenoglio JJ, Pham TD, Harken AH, Horowitz LH, Josephson ME, Witt AL. Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originates. Circulation. 1983;68:518-533.
41. Bolick DR, Hackel DB, Reimer KA, Ideker RE. Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia. Circulation. 1986;74:1266-1279.
42. De Bakker JMT, van Capelle FJL, Janse MJ, Wilde AAM, Coronel R, Becker AE, Dingemans KP, van Hemel NM, Hauer RNW, Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988; 77:589-606.
43. Lawton JS, Ellenbogen KA, Wood MA, Stambler BS, Herre JM, Nath S, Bernstein RC, DiMarco JP, Haines DE, Szentpetery S, Baker LD, Damiano RJ. Sensing lead-related complications in patients with transvenous implantable cardioverter-defibrillators. Am J Cardiol. 1996;78: 647-651.